The pair hopes to stimulate the immune system to tackle tumors bearing mutant KRas proteins, one of cancer’s toughest targets

Sales and earnings grow strongly for most firms, and the outlook is positive for the rest of the year

Manganese-hydrogen design boasts high capacity, long life, and the promise of low cost

Move follows report by food safety agency on health risks to bees

More than 16,000 people showed up to the meeting in New Orleans. Here are a few of their stories

Membership to NAS is among the most prestigious scientific honors in the U.S.

Theoretical model uses readily available data to predict catalysts for tackling energy challenges

Using a multitude of methods, chemists make unprecedented crowded alkyl amines; but one elusive target remains out of reach

BASF will buy agrochemical and seed businesses for $2 billion

German chemical maker seeks to balance technical support and basic R&D that can open new markets

Sales rise as the new firm with 2 old names leads the ranking

As wildfires increase in frequency across the globe, researchers hunt the smoke compounds that can seep into vineyards’ grapes and taint wine

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it

Combining expansion microscopy and STED improves resolution 30-fold relative to the diffraction limit

Manganese phthalocyanine catalyst shows preference for least-hindered benzylic C–H bonds

Engineered bacteria could be used for bioremediation of antibiotic-contaminated soils